Direct oral anticoagulants for electrical cardioversion

Open Access

17 July 2021

journal article
Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention

Vol. 20 (4), 2932
https://doi.org/10.15829/1728-8800-2021-2939

Abstract

The article discusses the issues of anticoagulant preparation for elective electrical cardioversion in patients with persistent atrial fibrillation. Updated preparation regimens for electrical cardioversion are proposed, as well as the potential of using direct oral anticoagulants for this purpose is discussed.

Keywords

This publication has 30 references indexed in Scilit:

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation
The New England Journal of Medicine, 2020
Utilization and Predictors of Electrical Cardioversion in Patients Hospitalized for Atrial Fibrillation
Cardiology Research and Practice, 2016
Health-Related Quality of Life in Patients With Atrial Fibrillation Treated With Rhythm Control Versus Rate Control
Circulation: Cardiovascular Quality and Outcomes, 2014
Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy
EP Europace, 2014
Thromboembolic Complications After Cardioversion of Acute Atrial Fibrillation
Journal of Invasive Cardiology, 2013
Silent Embolism After Electrical Cardioversion of Atrial Fibrillation: What Does Brain Magnetic Resonance Imaging Provide?
Revista Española de Cardiología (English Edition), 2012
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
The New England Journal of Medicine, 2008
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
The New England Journal of Medicine, 2002
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
The New England Journal of Medicine, 2002
Use of Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation
The New England Journal of Medicine, 2001